Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BBNX
BETA BIONICS, INC.
NASDAQ
$19.72
▲ UP 0.92% (0.18)

KEY STATISTICS

Market Cap$887.20 M
52w High$32.71
52w Low$8.80
Dividend Yield—
Frequency—
P/E-11.95
Volume992.33K
Shares Out.44.99M

COMPANY

LEADERSHIP

Sean T. Saint
CHIEF EXECUTIVE
Sean T. Saint

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 30, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
422

PRICE TARGET

Target High$22.00
Target Low$19.00
Target Median$22.00
Target Consensus$21.00

UPCOMING EARNINGS

DateOct 27, 2026
DayTuesday
Rev. Est.$35.04M
OCT
27
TUE

PRICE

$19.72 ▲ UP 0.92% (+$0.18)
$19.25$19.50$19.75$20.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM19.72

About Beta Bionics, Inc.

https://www.betabionics.com ↗

Beta Bionics, Inc. develops and commercializes innovative insulin delivery devices like the iLet Bionic Pancreas and Patch Pump to improve diabetes management for insulin-dependent individuals.

INDUSTRY

Medical - Devices

A PRODUCT BETA BIONICS, INC. IS KNOWN FOR

iLet Bionic Pancreas
iLet Bionic Pancreas

The iLet Bionic Pancreas is an autonomous insulin delivery system for type 1 diabetes that learns user needs and automatically manages blood glucose without requiring carbohydrate counting or manual dosing.

COMPETITORS

COMPETITOR
ABT COMPARE
DXCM COMPARE
MDT COMPARE
PODD COMPARE
TNDM COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
73
LISTED HERE
13
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.3M
IWM
0.02% · 1.0M
SCHA
0.02% · 193.7K
XHE
1.38% · 127.3K
TMSL
0.04% · 64.8K
SNSR
0.43% · 46.0K
XRSU.L
0.03% · 37.2K
DFAC
0.00% · 35.5K
AVSC
0.02% · 29.0K
SGRW
0.49% · 7.4K
GINN
0.07% · 7.0K
URTY
0.01% · 1.7K
RTYS.L
0.02% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
94.14%
HOLDERS
212
TOP 12 OF 212 · RANKED BY POSITION SIZE
Eventide Asset Management, LLC
6.3M sh · $98.05M
Soleus Capital Management, L.P.
4.4M sh · $68.85M
Farallon Capital Management LLC
4.3M sh · $85.72M
Morgan Stanley
4.3M sh · $66.86M
Wellington Management Group Llp
3.9M sh · $77.52M
Sands Capital Ventures, LLC
3.7M sh · $58.11M
Blackrock, Inc.
3.3M sh · $52.34M
Rtw Investments, LP
3.3M sh · $65.55M
Point72 Asset Management, L.P.
2.5M sh · $25.3M
Vanguard Group Inc
2.2M sh · $67.59M
Vestal Point Capital, LP
2.2M sh · $22.16M
Omega Fund Management, LLC
1.9M sh · $38.15M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Feider Stephen
Sale · 5.1K shares
2026-06-26
★
OFFICER: CHIEF FINANCIAL OFFICER
Feider Stephen
Purchase · 4.9K shares
2026-06-29
★
OFFICER: CHIEF FINANCIAL OFFICER
Feider Stephen
Purchase · 5.1K shares
2026-06-26
★
OFFICER: CHIEF FINANCIAL OFFICER
Feider Stephen
Sale · 4.9K shares
2026-06-29

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
NEUTRAL 2
OUTPERFORM 1
OVERWEIGHT 1
8 GRADES IN THE LAST 12 MONTHS
Goldman Sachs BUY Truist Securities BUY B of A Securities NEUTRAL Leerink Partners OUTPERFORM Stifel BUY Baird NEUTRAL Lake Street BUY Piper Sandler OVERWEIGHT

SECTORS PEERS

PEERPRICE
PLSE$47.57COMPARE
PGEN$6.95COMPARE
KMTS$25.64COMPARE
ORIC$13.24COMPARE
IMTX$9.45COMPARE
STAA$22.11COMPARE
AHCO$5.79COMPARE